GefitinibAcquired resistance and adenocarcinoma transformation to small cell lung cancer: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2015年 / 1574卷 / 1期

关键词：

D O I：

10.1007/s40278-015-1580-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：124 / 124

相关论文

共 50 条

[1] GefitinibAcquired resistance and adenocarcinoma transformation to small cell lung cancer: case report
[J]. Reactions Weekly, 2017, 1678 (1) : 91 - 91
[2] GefitinibAcquired resistance and adenocarcinoma transformation to small cell lung cancer: case report
[J]. Reactions Weekly, 2017, 1659 (1) : 134 - 134
[3] GefitinibAcquired resistance in Lung adenocarcinoma: case report
[J]. Reactions Weekly, 2018, 1683 (1) : 328 - 328
[4] GefitinibAcquired resistance in non-small cell lung cancer: case report
[J]. Reactions Weekly, 2017, 1660 (1) : 164 - 164
[5] GefitinibAcquired resistance in metastatic non-small cell lung cancer: case report
[J]. Reactions Weekly, 2020, 1813 (1) : 113 - 113
[6] OsimertinibOsimertinib resistance and transformation from adenocarcinoma to small cell lung cancer: case report
[J]. Reactions Weekly, 2020, 1791 (1) : 203 - 203
[7] Afatinib/erlotinib/gefitinibAcquired resistance in non-small cell lung cancer: case report
[J]. Reactions Weekly, 2018, 1705 (1) : 15 - 15
[8] AfatinibAcquired drug resistance in lung adenocarcinoma resulting in small cell lung cancer transformation: case report
[J]. Reactions Weekly, 2019, 1784 (1) : 19 - 19
[9] PembrolizumabDrug resistance and transformation of adenocarcinoma to small cell lung carcinoma: case report
[J]. Reactions Weekly, 2020, 1828 (1) : 410 - 410
[10] GefitinibDevelopment of acquired resistance to gefitinib with transformation of lung adenocarcinoma to metastatic small cell lung cancer: case report
[J]. Reactions Weekly, 2022, 1899 (1) : 198 - 198

← 1 2 3 4 5 →